Bright Minds BiosciencesDRUG 
$41.003.80%24h
3.80%24h
Global rank17322
Market cap$152.51M
Change 7d5.67%
YTD Performance2651.68%
SP500 benchmarkOutperform
P/E-20.71
P/S0
Revenue$0
Earnings-$5.18M
Dividend yield-
Main Sector
Healthcare
Category
Bright Minds Biosciences (DRUG) Total Liabilities
DRUG Total Liabilities in 2022: $197.29K
According to Bright Minds Biosciences latest financial reports the total liabilities of DRUG is $197.29K, an decrease of -81.82% to 2022. At the end of 2022 company had $1.08M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Bright Minds Biosciences is responsible for during its operational activities.
Bright Minds Biosciences (DRUG) Total Liabilities History from 2023 to 2022
-
Value:-
DRUG Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $197.29K | -81.82% |
| 2022 | $1.08M | 141.86% |
| 2021 | $448.58K | 323.11% |
| 2020 | $106.02K | - |
View the Top Total Liabilies Stocks
